Homeopathic treatment of warts

Phase 3

• Conditions: Health Condition 1: B079- Viral wart, unspecified

• Registration Number: CTRI/2023/08/055962
• Lead Sponsor: ehru Homoeopathic Medical College & Hospital, Govt. of NCT of Delhi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Suffering from cutaneous warts (non-genital; 2020 ICD-10-CM diagnosis code B07.9) for variable periods of time and not taking any other treatment for those warts for at least 1 month.

2. Patients already undergoing treatment for warts were recruited only after having completely stopped that therapy and with a subsequent wash-out phase of 1 month or more

3. Those aged between 18 and 65 years

4. Participants of either sex

5. Literate patients who can read English, Hindi and/or Bengali. Illiterate patients will be interviewed by the investigators maintaining privacy

Exclusion Criteria

1. Patients with anogenital and genital warts

2. Patients already taking any form of treatment or willing to continue so for warts

3. Vulnerable population â?? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill subjects

4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure

5. Pregnant and puerperal women, lactating mothers

6. Tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence

7. Self-reported immune-compromised state (e.g., HIV)

8. Undergoing homeopathic treatment for any chronic disease(s) within last 6 months

9. Simultaneous participation in any other clinical trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The number & size of each wart (measured by a millimeter scale on its longest diameter)Timepoint: Baseline, every month, up to 6 months

Secondary Outcome Measures

Name	Time	Method
Dermatology Life Quality Index (DLQI)Timepoint: Baseline, every month, up to 6 months